Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Robert T. Franke"'
Publikováno v:
Psychopharmacology. 235:99-108
Rationale 2-Bromoterguride, a dopamine D2 receptor partial agonist with antagonist properties at serotonin 5-HT2A receptors and α2C-adrenoceptors, meets the prerequisites of a putative atypical antipsychotic drug (APD). We recently showed that 2-bro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2ab2a3cf8e0b61b56cc1607097fa3c54
https://doi.org/10.1007/s00213-017-4747-x
https://doi.org/10.1007/s00213-017-4747-x
Publikováno v:
Psychopharmacology
Rationale Recently, we showed that 2-bromoterguride acted as a dopamine D2 receptor partial agonist, a serotonin 5-HT2A and α2C-adrenergic receptor antagonist, and exhibited antidopaminergic efficacy in amphetamine-induced locomotion (AIL) in rats w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ad0bae2f303798d448b4c170966319e
http://europepmc.org/articles/PMC4933731
http://europepmc.org/articles/PMC4933731
Autor:
Florian Jantschak, Dorothee Möller, Robert T. Franke, Harald Hübner, Peter Gmeiner, Heidrun Fink, Jan Brosda, Heinz H. Pertz
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 347(1)
Dopaminergic, serotonergic, and adrenergic receptors are targets for therapeutic actions in schizophrenia. Dopamine D2 receptor partial agonists such as aripiprazole represent a treatment option for patients with this severe disorder. The ineffective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5aa3b985b9f52d7d12f03d16d469baee
https://pubmed.ncbi.nlm.nih.gov/23863695
https://pubmed.ncbi.nlm.nih.gov/23863695
Autor:
Tarland, Emilia1, Franke, Robert T.1, Fink, Heidrun1, Pertz, Heinz H.2, Brosda, Jan1,3 jan.brosda@bfr.bund.de
Publikováno v:
Psychopharmacology. Jan2018, Vol. 235 Issue 1, p99-108. 10p. 1 Diagram, 1 Chart, 4 Graphs.